237 related articles for article (PubMed ID: 37390336)
1. Resolving therapy resistance mechanisms in multiple myeloma by multiomics subclone analysis.
Poos AM; Prokoph N; Przybilla MJ; Mallm JP; Steiger S; Seufert I; John L; Tirier SM; Bauer K; Baumann A; Rohleder J; Munawar U; Rasche L; Kortüm KM; Giesen N; Reichert P; Huhn S; Müller-Tidow C; Goldschmidt H; Stegle O; Raab MS; Rippe K; Weinhold N
Blood; 2023 Nov; 142(19):1633-1646. PubMed ID: 37390336
[TBL] [Abstract][Full Text] [Related]
2. Subclone-specific microenvironmental impact and drug response in refractory multiple myeloma revealed by single-cell transcriptomics.
Tirier SM; Mallm JP; Steiger S; Poos AM; Awwad MHS; Giesen N; Casiraghi N; Susak H; Bauer K; Baumann A; John L; Seckinger A; Hose D; Müller-Tidow C; Goldschmidt H; Stegle O; Hundemer M; Weinhold N; Raab MS; Rippe K
Nat Commun; 2021 Nov; 12(1):6960. PubMed ID: 34845188
[TBL] [Abstract][Full Text] [Related]
3. Resolving the spatial architecture of myeloma and its microenvironment at the single-cell level.
John L; Poos AM; Brobeil A; Schinke C; Huhn S; Prokoph N; Lutz R; Wagner B; Zangari M; Tirier SM; Mallm JP; Schumacher S; Vonficht D; Solé-Boldo L; Quick S; Steiger S; Przybilla MJ; Bauer K; Baumann A; Hemmer S; Rehnitz C; Lückerath C; Sachpekidis C; Mechtersheimer G; Haberkorn U; Dimitrakopoulou-Strauss A; Reichert P; Barlogie B; Müller-Tidow C; Goldschmidt H; Hillengass J; Rasche L; Haas SF; van Rhee F; Rippe K; Raab MS; Sauer S; Weinhold N
Nat Commun; 2023 Aug; 14(1):5011. PubMed ID: 37591845
[TBL] [Abstract][Full Text] [Related]
4. Integrative analysis of the genomic and transcriptomic landscape of double-refractory multiple myeloma.
Ziccheddu B; Biancon G; Bagnoli F; De Philippis C; Maura F; Rustad EH; Dugo M; Devecchi A; De Cecco L; Sensi M; Terragna C; Martello M; Bagratuni T; Kastritis E; Dimopoulos MA; Cavo M; Carniti C; Montefusco V; Corradini P; Bolli N
Blood Adv; 2020 Mar; 4(5):830-844. PubMed ID: 32126144
[TBL] [Abstract][Full Text] [Related]
5. Linking transcriptional and genetic tumor heterogeneity through allele analysis of single-cell RNA-seq data.
Fan J; Lee HO; Lee S; Ryu DE; Lee S; Xue C; Kim SJ; Kim K; Barkas N; Park PJ; Park WY; Kharchenko PV
Genome Res; 2018 Aug; 28(8):1217-1227. PubMed ID: 29898899
[TBL] [Abstract][Full Text] [Related]
6. Single-cell genetic analysis reveals the composition of initiating clones and phylogenetic patterns of branching and parallel evolution in myeloma.
Melchor L; Brioli A; Wardell CP; Murison A; Potter NE; Kaiser MF; Fryer RA; Johnson DC; Begum DB; Hulkki Wilson S; Vijayaraghavan G; Titley I; Cavo M; Davies FE; Walker BA; Morgan GJ
Leukemia; 2014 Aug; 28(8):1705-15. PubMed ID: 24480973
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic identification of subclones in multiple myeloma with different chemoresistant, cytogenetic and clonogenic potential.
Paíno T; Paiva B; Sayagués JM; Mota I; Carvalheiro T; Corchete LA; Aires-Mejía I; Pérez JJ; Sanchez ML; Barcena P; Ocio EM; San-Segundo L; Sarasquete ME; García-Sanz R; Vidriales MB; Oriol A; Hernández MT; Echeveste MA; Paiva A; Blade J; Lahuerta JJ; Orfao A; Mateos MV; Gutiérrez NC; San-Miguel JF
Leukemia; 2015 May; 29(5):1186-94. PubMed ID: 25388955
[TBL] [Abstract][Full Text] [Related]
8. Single-Cell Profiling Reveals Metabolic Reprogramming as a Resistance Mechanism in
Waldschmidt JM; Kloeber JA; Anand P; Frede J; Kokkalis A; Dimitrova V; Potdar S; Nair MS; Vijaykumar T; Im NG; Guillaumet-Adkins A; Chopra N; Stuart H; Budano L; Sotudeh N; Guo G; Grassberger C; Yee AJ; Laubach JP; Richardson PG; Anderson KC; Raje NS; Knoechel B; Lohr JG
Clin Cancer Res; 2021 Dec; 27(23):6432-6444. PubMed ID: 34518309
[TBL] [Abstract][Full Text] [Related]
9. The molecular spectrum and clinical impact of DIS3 mutations in multiple myeloma.
Weißbach S; Langer C; Puppe B; Nedeva T; Bach E; Kull M; Bargou R; Einsele H; Rosenwald A; Knop S; Leich E
Br J Haematol; 2015 Apr; 169(1):57-70. PubMed ID: 25521164
[TBL] [Abstract][Full Text] [Related]
10. Dissecting order amidst chaos of programmed cell deaths: construction of a diagnostic model for KIRC using transcriptomic information in blood-derived exosomes and single-cell multi-omics data in tumor microenvironment.
Wang C; He Y; Zheng J; Wang X; Chen S
Front Immunol; 2023; 14():1130513. PubMed ID: 37153569
[TBL] [Abstract][Full Text] [Related]
11. Spatial transcriptomics reveals discrete tumour microenvironments and autocrine loops within ovarian cancer subclones.
Denisenko E; de Kock L; Tan A; Beasley AB; Beilin M; Jones ME; Hou R; Muirí DÓ; Bilic S; Mohan GRKA; Salfinger S; Fox S; Hmon KPW; Yeow Y; Kim Y; John R; Gilderman TS; Killingbeck E; Gray ES; Cohen PA; Yu Y; Forrest ARR
Nat Commun; 2024 Apr; 15(1):2860. PubMed ID: 38570491
[TBL] [Abstract][Full Text] [Related]
12. Unstable Genome and Transcriptome Dynamics during Tumor Metastasis Contribute to Therapeutic Heterogeneity in Colorectal Cancers.
Cho SY; Chae J; Na D; Kang W; Lee A; Min S; Kang J; Choi B; Lee J; Sung CO; Chuang JH; Lee C; Lee WS; Park H; Kim JI
Clin Cancer Res; 2019 May; 25(9):2821-2834. PubMed ID: 30670495
[TBL] [Abstract][Full Text] [Related]
13. Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma.
Yao L; Wang JT; Jayasinghe RG; O'Neal J; Tsai CF; Rettig MP; Song Y; Liu R; Zhao Y; Ibrahim OM; Fiala MA; Fortier JM; Chen S; Gehrs L; Rodrigues FM; Wendl MC; Kohnen D; Shinkle A; Cao S; Foltz SM; Zhou DC; Storrs E; Wyczalkowski MA; Mani S; Goldsmith SR; Zhu Y; Hamilton M; Liu T; Chen F; Vij R; Ding L; DiPersio JF
Cancer Res; 2023 Apr; 83(8):1214-1233. PubMed ID: 36779841
[TBL] [Abstract][Full Text] [Related]
14. Molecular Crosstalk between Chromatin Remodeling and Tumor Microenvironment in Multiple Myeloma.
Chakraborty C; Mukherjee S
Curr Oncol; 2022 Dec; 29(12):9535-9549. PubMed ID: 36547163
[TBL] [Abstract][Full Text] [Related]
15. Single-cell profiling of multiple myeloma reveals molecular response to FGFR3 inhibitor despite clinical progression.
Croucher DC; Devasia AJ; Abelman DD; Mahdipour-Shirayeh A; Li Z; Erdmann N; Tiedemann R; Pugh TJ; Trudel S
Cold Spring Harb Mol Case Stud; 2023 Apr; 9(2):. PubMed ID: 36639200
[TBL] [Abstract][Full Text] [Related]
16. Multi-omic analysis of the tumor microenvironment shows clinical correlations in Ph1 study of atezolizumab +/- SoC in MM.
Wong S; Hamidi H; Costa LJ; Bekri S; Neparidze N; Vij R; Nielsen TG; Raval A; Sareen R; Wassner-Fritsch E; Cho HJ
Front Immunol; 2023; 14():1085893. PubMed ID: 37559718
[TBL] [Abstract][Full Text] [Related]
17. A Bayesian framework to study tumor subclone-specific expression by combining bulk DNA and single-cell RNA sequencing data.
Qiao Y; Huang X; Moos PJ; Ahmann JM; Pomicter AD; Deininger MW; Byrd JC; Woyach JA; Stephens DM; Marth GT
Genome Res; 2024 Feb; 34(1):94-105. PubMed ID: 38195207
[TBL] [Abstract][Full Text] [Related]
18. Molecular basis of clonal evolution in multiple myeloma.
Furukawa Y; Kikuchi J
Int J Hematol; 2020 Apr; 111(4):496-511. PubMed ID: 32026210
[TBL] [Abstract][Full Text] [Related]
19. Hunting down the dominating subclone of cancer stem cells as a potential new therapeutic target in multiple myeloma: An artificial intelligence perspective.
Lee LX; Li SC
World J Stem Cells; 2020 Aug; 12(8):706-720. PubMed ID: 32952853
[TBL] [Abstract][Full Text] [Related]
20. Single‑cell multi‑omics advances in lymphoma research (Review).
Jin C; Zhou D; Li J; Bi L; Li L
Oncol Rep; 2023 Oct; 50(4):. PubMed ID: 37615192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
